Experimental cancer drug trial halted early
NCT ID NCT05904496
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This early-stage study tested a new drug called BGB-30813, alone or with another drug (tislelizumab), in people with advanced solid tumors that had not responded to standard treatments. The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601-1915, United States
-
Hospital Universitario Vall Dhebron
Barcelona, 08035, Spain
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia
-
Md Anderson Cancer Center
Houston, Texas, 77030-3907, United States
-
Monash Health
Clayton, Victoria, 3168, Australia
-
Next Oncology
San Antonio, Texas, 78229-6028, United States
-
Peter Maccallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
-
Shandong Provincial Hospital
Jinan, Shandong, 250021, China
-
Start Madrid Fundacion Jimenez Diaz
Madrid, 28040, Spain
Conditions
Explore the condition pages connected to this study.